The effects of estrogen on bone are mediated mainly via estrogen receptor (ER)␣. ER␣ in osteoclasts (hematopoietic origin) is involved in the trabecular bone-sparing effects of estrogen, but conflicting data are reported on the role of ER␣ in osteoblast lineage cells (nonhematopoietic origin) for bone metabolism. Because Cre-mediated cellspecific gene inactivation used in previous studies might be confounded by nonspecific and/or incomplete cell-specific ER␣ deletion, we herein used an alternative approach to determine the relative importance of ER␣ in hematopoietic (HC) and nonhematopoietic cells (NHC) for bone mass. Chimeric mice with selective inactivation of ER␣ in HC or NHC were created by bone marrow transplantations of wild-type (WT) and ER␣-knockout (ER␣ Ϫ/Ϫ ) mice. Estradiol treatment increased both trabecular and cortical bone mass in ovariectomized WT/WT (defined as recipient/donor) and WT/ER␣ Ϫ/Ϫ mice but not in ER␣ Ϫ/Ϫ /WT or ER␣ Ϫ/Ϫ /ER␣ Ϫ/Ϫ mice. However, estradiol effects on both bone compartments were reduced (ϳ50%) in WT/ ER␣ Ϫ/Ϫ mice compared with WT/WT mice. The effects of estradiol on fat mass and B lymphopoiesis required ER␣ specifically in NHC and HC, respectively. In conclusion, ER␣ in NHC is required for the effects of estrogen on both trabecular and cortical bone, but these effects are enhanced by ER␣ in HC.
estrogen; estrogen receptor-␣; bone marrow transplantation; trabecular bone; cortical bone ESTROGEN REGULATES VARIOUS BIOLOGICAL PROCESSES, and one important target tissue is bone. The reduction in estrogen levels seen at menopause is strongly associated with postmenopausal osteoporosis, and low estrogen levels have also been associated with low bone mass and increased fracture risk in elderly men (8, 17, 26) .
The effects of estrogen are mediated primarily via the nuclear estrogen receptors (ERs) ER␣ and ER␤. ER␣ is the main mediator of the trabecular and cortical bone protective effects of estrogen (2, 23) . ER␣ expression is found both in nonhematopoietic cells (NHC), including the bone-forming osteoblasts and osteocytes, which are of mesenchymal origin, and in hematopoietic cells (HC), including the bone-resorbing osteoclasts (27) . Treatment with estrogen has beneficial effects on bone mass but is associated with several side effects. Therefore, it is important to determine the target cell(s) mediating the positive ER␣-mediated estrogenic effects on bone to be able to separate the positive estrogen effects on bone from the negative side effects.
To determine the primary ER␣ target cell for the effects of estrogen on bone, Cre-mediated cell-specific inactivation of ER␣ in osteoblasts and osteoclast lineage cells have been used in several studies. Deletion of ER␣ in osteoclasts using cathepsin-Cre mice showed that ER␣ in osteoclasts is important for the maintenance of trabecular bone in female mice, whereas cortical bone is unaffected (19) . A subsequent study showed that deletion of ER␣ in myeloid cells, including monocytes, macrophages, and granulocytes in addition to osteoclasts, using LysM-Cre mice, also affects trabecular but not cortical bone in female mice (15) . Collectively, these two studies demonstrate clearly that ER␣ in osteoclasts is involved in the regulation of trabecular bone in females.
Several in vitro studies have suggested that ER␣ in osteoblasts/osteocytes is also of importance in the regulation of bone metabolism (9, 11, 26) , but it was only recently that the in vivo role of ER␣ in osteoblast lineage cells was evaluated using in total six different Cre-mice in five independent studies (1, 14, 18, 22, 29) . Almeida et al. (1) demonstrated that mice with inactivation of ER␣ using Prx1-Cre mice (recombination in mesenchymal progenitors) or osterix1-Cre mice (recombination in osteoblast progenitors) had reduced cortical but not trabecular bone mass, whereas these two bone compartments were not affected when Col1␣1-Cre mice (recombination in mature osteoblasts) was used for the inactivation of ER␣, suggesting that osteoblast progenitors mediate the effect of estrogens on cortical but not trabecular bone. In contrast, three other studies demonstrated that the trabecular bone was reduced in mice with osteoblast-specific inactivation of ER␣ when both Runx2-Cre mice [recombination in early osteoblasts (22) ] and osteocalcin-Cre mice [recombination in mature osteoblasts, (14, 18) ] were used for the inactivation. In a fifth study, ER␣ was inactivated in late osteoblasts/osteocytes using Dmp1-Cre mice (29) , and although gonadal intact female mice had normal trabecular bone mass, the estrogenic response to estradiol (E 2 ) in ovariectomized (OVX) mice was reduced for this mouse strain. These studies demonstrate that there is an inconsistency regarding the role of ER␣ in osteoblast lineage cells for the regulation of bone homeostasis. It is possible that nonspecific or incomplete cell-specific inactivation of ER␣ for some of the used Cre-mouse models might have contributed to these conflicting results.
Herein, we used an alternative approach to determine the relative importance of ER␣ in HC and NHC for the effect of estrogen on both trabecular and cortical bone. Chimeric mice with selective inactivation of ER␣ in HC or NHC were created by bone marrow transplantations of wild-type (WT) and ER␣-knockout (ER␣ Ϫ/Ϫ ) mice and the estrogenic response in OVX mice was evaluated (Fig. 1A) .
MATERIALS AND METHODS

Animals
All experimental procedures involving animals were approved by the Ethics Committee of the University of Gothenburg. Female total ER␣-inactivated mice (ER␣ Ϫ/Ϫ ) and WT littermates were used. ER␣ Ϫ/Ϫ mice have a deletion in exon 3 of the ER␣ gene and do not express any of the isoforms of the ER␣ protein. The total ER␣ Ϫ/Ϫ mice and corresponding WT (ER␣ ϩ/ϩ ) littermates were inbred C57BL/6 mice and generated by breeding male ER␣ ϩ/Ϫ with female ER␣ ϩ/Ϫ mice that were obtained as described previously (3) . Ovariectomy was performed at 10 wk of age through a midline incision of the skin and flank incisions of the peritoneum (Fig. 1) . Surgery was performed under anesthesia with isoflurane (Pfizer, Täby, Sweden). Carprofen (OrionPharma, Espoo, Finland) was used postoperatively as an analgesic.
Preparation of Cells for Transplantation
Donor WT and ER␣ Ϫ/Ϫ mice were treated with enrofloxacin antibiotics (0.6 mg/ml drinking water; Baytril Vet, Bayer HealthCare, Copenhagen, Denmark) for 1 wk prior to euthanization. Bone marrow (BM) cells were obtained from freshly isolated femur and tibia by flushing and from hip/pelvic bone by crushing with mortar and pestle. Cells were placed in ␣-MEM medium and filtered through a 100-m cellstrainer. Hematopoietic stem cells (HSC) were purified after centrifugation (1,500 rpm, 10 min) using the EasySep Mouse Hematopoietic Progenitor Enrichment Kit (Stemcell Technologies, Grenoble, France) according to kit instructions. Enriched HSCs were resuspended in PBS and adjusted to 1.25 ϫ 10 6 cells/ml.
BM Transplantation
BM transplantation was performed 2 wk after ovariectomy (Fig. 1 ). OVX ER␣ Ϫ/Ϫ mice and WT littermates treated with enrofloxacin antibiotics in the drinking water (0.6 mg/ml; Baytril Vet) for 1 wk were lethally irradiated with 8. 
/ ER␣
Ϫ/Ϫ ; n ϭ 18). Reconstituted mice were treated with enrofloxacin (0.6 mg/ml) and placed in new autoclaved cages every day for 2 wk to prevent infection during the aplastic phase.
Hormone Treatment
Two weeks after the BM transplantation (Fig. 1) , the mice were inserted with a subcutaneous slow-release pellet (Innovative Research of America) with E2 (167 ng·mouse Ϫ1 ·day Ϫ1 ) or placebo during isoflurane anesthesia. Four weeks after the start of treatment, the mice were anesthetized with Ketalar/Domitor (Pfizer), bled, and euthanized by cervical dislocation. Serum was stored individually at Ϫ20°C until use. Uterus, gonadal fat, and thymus were collected and weighed.
Assessment of Bone Parameters
High-resolution microcomputed tomography. High-resolution microcomputed tomography (CT) analyses were performed on the distal femur by using an 1172 model CT (Bruker MicroCT, Aartselaar, Belgium). The femurs were imaged with an X-ray tube voltage of 50 kV and current of 201 A, with a 0.5-mm aluminum filter. The scanning angular rotation was 180°and the angular increment 0.70°. The voxel size was 4.48 m isotropically. The NRecon (version 1.6.9) was employed to perform the reconstruction following the scans. The cortical measurements in the femur were performed in the diaphyseal region of femur starting at a distance of 5.23 mm from the growth plate and extending a further longitudinal distance of 135 m in the proximal direction. The trabecular bone proximal to the distal growth plate was selected for analyses within a conforming volume of interest (cortical bone excluded), commencing at a distance of 426 m from the growth plate and extending a further longitudinal distance of 135 m in the proximal direction. For bone mineral density analysis, the equipment was calibrated with ceramic standard samples.
Histomorphometry. Bone histomorphometry was applied to analyze trabecular bone in the vertebral body of undecalcified lumbar ) or placebo for 4 wk. B and C: RNA was prepared from bone marrow (B) and spleen (C), and ER␣ expression was determined using real-time PCR. Values are presented as means Ϯ SE; n ϭ 9 -10. ***P Ͻ 0.001 vs. WT/WT, Student's t-test. BMT, bone marrow transplantation.
vertebrae L4 stored in 70% EtOH. Each sample was dehydrated in an increasing series of EtOH concentrations, defatted in xylene, and embedded in methyl methacrylate (Technovit 9100 New; Heraeus Kulzer, Hanau, Germany). The embedded sample was sectioned longitudinally in a coronal plane using a fully motorized rotary microtome and a tungsten carbide knife. Plastic sections were obtained from three standardized sites of vertebral body cavity with a distance of 100 m between adjacent sites. These three sites were named site A, site B, and site C. In each site, static parameters were determined in a 4-m-thick section stained in Masson-Goldner's Trichrome (3a) . In each section, trabecular bone was analyzed using two adjacent fields with a total area of 1.5 mm 2 . Images were captured using a Nikon Eclipse 80i light microscope connected to a Sony DXC-S500 video camera and analyzed using OsteoMeasure histomorphometry system (OsteoMetrics, Atlanta, GA), following the guidelines of the American Society for Bone and Mineral Research (2a).
Three-point bending. The femurs were fixed in formaldehyde for 2 days and after that stored in 70% ethanol. The biomechanics were analyzed with the three-point bending test (span length 55 mm, loading speed 0.155 mm/min) for the midfemur using the Instron universal testing machine (Instron 3366; Instron, Norwood, MA). The biomechanical parameters were calculated based on the recorded load deformation curves.
BM Cell Preparation and Flow Cytometry
BM cells were harvested from one femur using a syringe with 5 ml of PBS. Pelleted cells were resuspended in Tris-buffered 0.83% NH 4Cl solution to lyse erythrocytes and washed in PBS. The total number of leukocytes was analyzed using an automated cell counter (Sysmex, Hamburg, Germany). Cells were stained with V450-conjugated anti-B220 and analyzed using a FACSCanto instrument (Becton Dickinson, Oxford, UK). FlowJo software version 8.5.2 (Tree Star, Ashland, OR) was used for data analysis.
Real-Time PCR
RNA was isolated from BM and spleen using the RNeasy kit (Qiagen, Chatswort, CA). The amplifications were performed using the StepOnePlus Real-Time PCR System (PE Applied Biosystems, Stockholm, Sweden), using Assay-on-Demand primer and probe sets (PE Applied Biosystems) labeled with the reporter fluorescent dye FAM. Predesigned primers and a probe labeled with the reporter fluorescent dye VIC, which was specific for 18S ribosomal RNA, were included as an internal standard. The assay identification number was ER␣ Mm00433147_m1.
Statistical Analyses
Values are given as means Ϯ SE. The statistical difference between OVX ϩ placebo and OVX ϩ E2 was calculated using Student's t-test. The statistical differences in E 2 response between the WT/WT and the WT/ER␣ Ϫ/Ϫ group were calculated by the interaction P value from a two-way-ANOVA that included donor genotype (WT or ER␣ Ϫ/Ϫ ) and treatment (OVX ϩ placebo or OVX ϩ E 2). (Fig. 1A) . ER␣ Ϫ/Ϫ mice have increased circulating sex steroid levels due to disturbed negative feedback (12) . Since sex steroids have been shown to protect HC against irradiation (5, 24) , all mice were OVX prior to irradiation to prevent unequal protection of HC in WT and ER␣ Ϫ/Ϫ recipients. To verify successful BM transplantations, ER␣ expression was measured in BM and spleen, two hematopoietic tissues. (Ϫ93 and Ϫ82%, respectively, P Ͻ 0.05, Student's t-test), confirming that WT/ER␣ Ϫ/Ϫ mice were successfully reconstituted with ER␣ Ϫ/Ϫ hematopoietic progenitor cells (Fig. 1, B  and C) . Furthermore, ER␣ expression was not significantly altered between ER␣ Ϫ/Ϫ /WT mice and WT/WT mice in BM and spleen, demonstrating successful reconstitution of WT hematopoietic progenitor cells in the ER␣ Ϫ/Ϫ mice (Fig. 1, B and C) .
RESULTS AND DISCUSSION
Generation of Chimeric Mice With Selective Inactivation of ER␣ Expression in HC and NHC
Estrogenic Response in Uterus and Gonadal Fat is Dependent on ER␣ Expression in NHC, Whereas the Effect on B-Cell Frequency in BM is Dependent on ER␣ Expression in HC
The uterus is a primary estrogen organ, and unopposed estrogen treatment results in uterine cell proliferation and increased risk of endometrial cancer (7) . The proliferative effect on the uterus has been shown to be mediated via ER␣ (13) , and we demonstrated recently that the AF-1 domain of the ER␣ is important for this effect (2) . Four weeks of treatment with E 2 resulted in a 12-fold increase in uterine weight in both WT/WT mice and mice lacking ER␣ in HC (WT/ ER␣ Ϫ/Ϫ ) compared with placebo treatment (Fig. 2A ). In contrast, mice lacking ER␣ in NHC (ER␣ Ϫ/Ϫ /WT and ER␣ Ϫ/Ϫ / ER␣ Ϫ/Ϫ ) did not respond to E 2 regarding uterine growth, demonstrating, as expected, that estrogenic effects on the uterus are mediated via ER␣ in NHC.
Estrogen regulates adipose tissue mass, and this regulation is mediated via ER␣ (4, 20) . HC in the adipose tissue have been implicated in obesity (28), and we evaluated the importance of ER␣ expression in HC vs. NHC for the fat-reducing effect of E 2 in OVX mice. E 2 treatment resulted in a 2.2-fold decrease in gonadal fat weight in OVX WT/WT mice and a 2.5-fold decrease in OVX WT/ER␣ Ϫ/Ϫ mice compared with placebo treatment (Fig. 2B) . In contrast, treatment with E 2 did not have an effect on gonadal fat weight in ER␣
Ϫ/Ϫ mice, demonstrating that ER␣ expression in NHC is required for the estrogenic effects on fat mass in OVX mice. This finding is consistent with a report describing that hypothalamic ER␣ is crucial for the fat-reducing effect of estrogen in OVX mice (30) . In contrast, it has been reported that lack of ER␣ in HC of gonadal intact female mice results in increased adipose tissue mass, suggesting that although ER␣ in NHC is crucial for the effect of estrogen on fat mass, ER␣ in HC might in some situations contribute to this effect (21) .
Estrogen has profound effects on the immune system and is known to regulate B lymphopoiesis (16) . This regulation is mediated via ER␣, and it has been shown in males, using a BM transplantation approach, that the effect of estrogen on the regulation of B lymphopoiesis is mediated mainly via ER␣ expression in HC (25) . We detected a significant E 2 -induced decrease in the frequency of B lymphocytes, estimated by measurement of B220-positive cells in BM, in mice with an intact ER␣ expression in HC (WT/WT and ER␣ Ϫ/Ϫ /WT mice), whereas no estrogenic response was detected in mice lacking ER␣ expression in HC (WT/ER␣ Ϫ/Ϫ and ER␣ (Fig. 2C) . Thus, our data demonstrated that ER␣ expression in HC is also required for the effect on B-cells in female mice.
ER␣ Expression in NHC is Required for the Effects of Estrogen Treatment on Both Trabecular and Cortical Bone
As described above, conflicting data have been reported previously on the role of ER␣ in NHC vs. HC for bone mass (1, 6, 14, 15, 18, 19, 22, 29) . To determine the importance of ER␣ in HC vs. NHC, the bone phenotype was characterized thoroughly in our chimeric mice. Since deletion of ER␣ expression in specific cell types has been shown to affect trabecular and cortical bone differentially (1, 15, 19, 29) , we used high-resolution CT of the femur diaphysis and histomorphometry of the vertebrae (L 4 ) to be able to separate the effects on the two bone compartments.
Cortical bone comprises Ͼ80% of the skeleton and has been suggested to be the main skeletal target for the physiological effects of estrogen (9) . We investigated cortical bone parameters using high-resolution CT, and E 2 treatment resulted in increased cortical bone area and thickness in WT/WT (ϩ82 and ϩ111%, P Ͻ 0.001, respectively) and WT/ER␣ Ϫ/Ϫ mice (ϩ44 and ϩ52%, P Ͻ 0.001, respectively), whereas no E 2 response was detected in ER␣ (Fig. 3, A and B) . This finding of a crucial role of ER␣ in NHC for cortical bone mass in female mice is consistent with recent reports on cell-specific ER␣ inactivation in osteoblast lineage cells using three different Cre-mouse models (osterixCre, Prx1-Cre, and osteocalcin-Cre) (1, 14, 18) , whereas this cortical bone effect was not seen when ER␣ was inactivated using the Col1␣1 or DMP1-Cre mice (1, 29) . Collectively, these studies provide strong evidence that ER␣ in early but not late osteoblasts is crucial for cortical bone in female mice. The augmenting effect of estrogen on cortical bone thickness in adult OVX female mice is mainly the result of an enhanced endosteal bone apposition (10) . E 2 treatment decreased the endosteal circumference in WT/WT (Ϫ28%, P Ͻ 0.001) and WT/ER␣ Ϫ/Ϫ mice (Ϫ12%, P Ͻ 0.05), whereas no effect on endosteal bone apposition was detected in mice lacking ER␣ expression in NHC (ER␣ Ϫ/Ϫ /WT and ER␣ ·day Ϫ1 ) or placebo for 4 wk. Cortical bone parameters were analyzed in a middiaphyseal scan of the femur using high-resolution microcomputed tomography. Cortical porosity was analyzed in total bone and in the outer 50 m or the cortical bone. *P Ͻ 0.05 and ***P Ͻ 0.001, Student's t-test. treatment in all four groups ( Table 1 ). The cortical bone mineral density was unaffected by E 2 treatment regardless of ER␣ expression in HC or NHC (Fig. 3C) . The increase in cortical bone mass was associated with an increase in the maximal load at failure (F max ) in WT/WT (ϩ29%, P Ͻ 0.001) and WT/ER␣ Ϫ/Ϫ (ϩ22%, P Ͻ 0.001) mice, as measured by three-point bending, whereas no effect on the biomechanical properties of the bone was detected in mice lacking ER␣ expression in NHC (Fig. 3D) . We also analyzed the cortical porosity and found it to be increased after E 2 treatment in WT/WT (ϩ369%, P Ͻ 0.001) and WT/ER␣ Ϫ/Ϫ (ϩ284%, P Ͻ 0.001) mice, whereas no E 2 effect was detected in ER␣ Ϫ/Ϫ /WT or ER␣ Ϫ/Ϫ /ER␣ Ϫ/Ϫ mice (Table 1) . However, a subanalysis of the cortical porosity of the outer 50 m of the bone shaft revealed unchanged porosity after E 2 treatment between all four groups (Table 1 ). This may be explained by the fact that E 2 treatment results in endosteal accumulation of trabecularized bone in the cortical bone shaft, leading to apparent increased cortical porosity ( Fig. 3E and Table 1 ).
The trabecular bone volume per total volume (BV/TV) was increased significantly after E 2 treatment in vertebrae of WT/WT mice (ϩ208%, P Ͻ 0.001) and WT/ER␣ Ϫ/Ϫ mice (ϩ151%, P Ͻ 0.001), whereas no estrogenic effect was detected in mice lacking ER␣ expression in NHC (ER␣ Ϫ/Ϫ /WT and ER␣ Ϫ/Ϫ /ER␣ Ϫ/Ϫ mice) (Fig. 3, F and I) . Analysis of trabecular number (Trab.N.) and trabecular separation (Trab.Sp) revealed a similar pattern, with a significant increase in Trab.N. and decrease in Trab.Sp after E 2 treatment in WT/WT (P Ͻ 0.001) and WT/ER␣ Ϫ/Ϫ (P Ͻ 0.001) mice compared with placebo, whereas mice lacking ER␣ expression in NHC (ER␣ Ϫ/Ϫ /WT and ER␣ Ϫ/Ϫ /ER␣ Ϫ/Ϫ mice) did not respond to E 2 treatment (Fig. 3, G and H ). These data demonstrate that ER␣ expression in NHC is required for E 2 to be able to elicit a stimulatory response in trabecular bone. Cells within the osteoblast lineage are strong candidate NHC types for mediating the estrogenic effects on trabecular bone since it has been demonstrated in some (14, 18, 22, 29) , but not all (1) recent reports, using Cre-mediated cell-specific ER␣ inactivation, that ER␣ in osteoblasts/osteocytes is involved in the regulation of trabecular bone mass.
ER␣ in HC Enhances the Stimulatory Effect of E 2 on Both Trabecular and Cortical Bone
Our data demonstrate that ER␣ expression in NHC is required for E 2 effects on both cortical and trabecular bone, whereas ER␣ expression solely in HC is not sufficient to generate an estrogenic response in either cortical or trabecular bone. Interestingly, in contrast to the similarity between the E 2 effect in WT/WT and WT/ER Ϫ/Ϫ mice on uterine growth and gonadal fat reduction, the E 2 response in WT/ER␣ Ϫ/Ϫ mice was significantly decreased compared with the E 2 response in WT/WT mice for both cortical (cortical thickness: Ϫ53%, P Ͻ 0.05) and trabecular (BV/TV: Ϫ27%, P Ͻ 0.01) bone parameters (Fig. 3) . This suggests that ER␣ expression in HC enhances but is not required for estrogenic effects on both cortical and trabecular bone in female mice. Thus, ER␣ expression in HC potentiates the estrogenic bone effects, but this enhancing effect requires ER␣ expression in NHC. Our result that the estrogenic response in trabecular bone is enhanced by ER␣ in HC is supported by the finding that female mice lacking ER␣ expression in osteoclast lineage cells have reduced trabecular bone mass (15, 19) . However, we show that ER␣ in HC enhances the E 2 response not only on trabecular but also cortical bone, whereas the previous studies detected only protective effects of ER␣ in myeloid cells/osteoclasts on trabecular bone. These conflicting results might be explained by the fact that other, nonmyeloid, HC are involved in the estrogenic effects on cortical bone or that the cell-specific inactivation of ER␣, using Cre-mediated inactivation, was partly incomplete.
Conclusion
ER␣ expression in NHC, but not in HC, is required for the effects of estrogen treatment on both trabecular and cortical bone in female mice. However, ER␣ in HC enhances the stimulatory effect of E 2 on both bone compartments in the presence of ER␣ in NHC.
